Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Candida krusei surface antigens represent a diverse group of molecules located on the outermost layer of the fungal cell wall, including mannoproteins, beta-glucans, and chitin (Source: NCBI, PMC4202231). These antigens play critical roles in maintaining structural integrity, facilitating adhesion to host tissues, and modulating the host immune response during infection (Source: Mycology Online). Candida krusei (also known as Pichia kudriavzevii) is a significant opportunistic pathogen, particularly noted for its intrinsic resistance to fluconazole, making its surface components vital targets for alternative therapeutic strategies (Source: CDC). Drugs such as echinocandins target the synthesis of specific surface components like (1,3)-beta-D-glucan, leading to cell wall instability and lysis (Source: FDA). Additionally, these antigens serve as important diagnostic biomarkers and are being explored as potential targets for vaccine development and monoclonal antibody therapies to combat invasive candidiasis (Source: PubMed, 28604330). The unique composition of the C. krusei cell wall contributes to its environmental resilience and its ability to colonize diverse niches within the human host (Source: StatPearls, NBK459131). Understanding these surface structures is essential for developing precision diagnostics that can distinguish C. krusei from other Candida species (Source: Journal of Fungi).
Inhibition of (1,3)-beta-D-glucan synthase (echinocandins); binding to ergosterol to form membrane pores (polyenes); inhibition of lanosterol 14-alpha-demethylase (azoles).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Candida krusei surface antigens.